In LC 5 we observe that sensitivity to the HDAC-inhibitor panobinostat is associated with C/EBPδ, a transcription factor that regulates cell cycle progression and apoptotis, and is therefore a putative tumor suppressor [36]. The gene discussed is HDAC9; the disease is neoplasm.